Skip to main content

Discreet, Closed-Loop Support for Freezing of Gait

FoGO is a wearable system designed to help people with Parkinson's disease who experience Freezing of Gait (FoG). Using real-time detection and vibrotactile cueing, FoGO aims to provide just-in-time assistance during critical mobility moments.

Understanding Freezing of Gait

Freezing of Gait (FoG) is a debilitating symptom affecting many people with Parkinson's disease, causing sudden, involuntary stops during walking.

Turning

Episodes often occur when changing direction or navigating turns

Initiation

Difficulty starting to walk from a standing position

Doorways

Freezing commonly happens when passing through doorways

Narrow Spaces

Confined areas can trigger sudden stopping episodes

The FoGO Approach

A closed-loop system that senses, detects, and responds to potential freezing episodes in real-time

01

Sense

Ankle-mounted sensors continuously monitor gait patterns using high-precision IMU technology

02

Detect

Edge-based machine learning analyzes movement patterns in real-time to identify potential FoG episodes

03

Cue

Vibrotactile feedback provides discreet rhythmic cues to help resume normal walking patterns

Sense
Detect
Cue
Resume

Why Vibrotactile Cueing?

Discreet & Non-Auditory

Vibration cues are private and don't draw attention in public settings, reducing stigma concerns

Comfortable for Daily Use

Designed to be worn throughout the day without discomfort or interference with normal activities

Evidence-Based Approach

Vibrotactile cueing has shown promise in research for gait regulation in Parkinson's disease

Personalized Intensity

Adjustable cue strength to match individual sensitivity and preference requirements

AI-generated illustration placeholder

Wearable device concept

Evidence Snapshot

Our development approach is grounded in evidence-based engineering and clinical validation planning

0ms
Target Latency
Edge processing for real-time response
0+ hrs
Runtime Goal
Full-day battery life target
85-92%
Detection Range
Prototype performance targets
0.0 FP/min
False Positive Target
Balancing sensitivity and specificity

Clinical Pilot Planning

We are preparing for structured clinical validation with planned pilot studies involving:

0+
Target Participants
0+
Week Study Duration
Multiple
Clinical Partners

Use Cases

FoGO is being designed to support multiple contexts of care and daily living

In-Clinic Evaluation

Assist clinicians in assessing FoG patterns and severity during consultations and treatment planning

At-Home Support

Provide continuous monitoring and cueing assistance during daily activities in home environments

Rehab Collaboration

Support physical therapy programs with objective gait data and targeted intervention assistance

Research & Clinical Collaborations

We are actively building partnerships with leading research institutions and healthcare providers

Partner logos and collaboration details will be added pending approval and partnership agreements

Interested in FoGO?

Whether you're a clinician, researcher, healthcare system, or potential partner, we'd love to hear from you and explore how we can collaborate.